Germline variants in exonic regions have limited impact on immune checkpoint blockade clinical outcomes in advanced melanoma von Montaudié, Henri, Beranger, Guillaume Emmanuel, Reinier, Frédéric, Nottet, Nicolas, Martin, Hélène, Picard‐Gauci, Alexandra, Troin, Laura, Ballotti, Robert, Passeron, Thierry

Volltext

Successful rechallenge with avelumab in a patient with advanced Merkel cell carcinoma who presented pembrolizumab‐induced myositis von Bertold, Clémence, Troin, Laura, Chassang, Madleen, Passeron, Thierry, Doyen, Jérôme, Montaudié, Henri, Picard‐Gauci, Alexandra

Volltext

Recurrence of metastatic Merkel carcinoma after cessation of avelumab in a patient previously with a complete response von Picard‐Gauci, Alexandra, Troin, Laura, Chassang, Madleen, Passeron, Thierry, Montaudié, Henri

Volltext

Pathological complete response to neoadjuvant pembrolizumab in a patient with metastatic cutaneous squamous cell carcinoma von Blaise, Manon, Poissonnet, Gilles, Cardot-Leccia, Nathalie, Sudaka, Anne, Velin, Marine, Chassang, Madleen, Razzouk-Cadet, Micheline, Picard-Gauci, Alexandra, Passeron, Thierry, Montaudié, Henri

Volltext

ITGBL1 is a new immunomodulator that favors development of melanoma tumors by inhibiting natural killer cells cytotoxicity von Cheli, Yann, Tulic, Meri K., El Hachem, Najla, Nottet, Nicolas, Jacquel, Arnaud, Gesson, Maeva, Strub, Thomas, Bille, Karine, Picard-Gauci, Alexandra, Montaudie, Henri, Beranger, Guillaume E., Passeron, Thierry, Close, Pierre, Bertolotto, Corine, Ballotti, Robert

Volltext

Correction to: ITGBL1 is a new immunomodulator that favors development of melanoma tumors by inhibiting natural killer cells cytotoxicity von Cheli, Yann, Tulic, Meri K, El Hachem, Najla, Nottet, Nicolas, Jacquel, Arnaud, Gesson, Maeva, Strub, Thomas, Bille, Karine, Picard-Gauci, Alexandra, Montaudié, Henri, Beranger, Guillaume E, Passeron, Thierry, Close, Pierre, Bertolotto, Corine, Ballotti, Robert

Volltext

Baseline and early functional immune response is associated with subsequent clinical outcomes of PD-1 inhibition therapy in metastatic melanoma patients von Gérard, Alexandre, Doyen, Jerome, Cremoni, Marion, Bailly, Laurent, Zorzi, Kevin, Ruetsch-Chelli, Caroline, Brglez, Vesna, Picard-Gauci, Alexandra, Troin, Laura, Esnault, Vincent L.M., Passeron, Thierry, Montaudié, Henri, Seitz-Polski, Barbara

Volltext

Association of TRF2 expression and myeloid-derived suppressor cells infiltration with clinical outcome of patients with cutaneous melanoma von Ilié, Marius, Lantéri, Elisabeth, Chamorey, Emmanuel, Thamphya, Brice, Hamila, Marame, Montaudié, Henri, Picard-Gauci, Alexandra, Gardrat, Sophie, Passeron, Thierry, Lassalle, Sandra, Long-Mira, Elodie, Cherfils-Vicini, Julien, Gilson, Eric, Hofman, Véronique, Hofman, Paul

Volltext

Comparison of Two Rapid Assays for the Detection of BRAF V600 Mutations in Metastatic Melanoma including Positive Sentinel Lymph Nodes von Long-Mira, Elodie, Picard-Gauci, Alexandra, Lassalle, Sandra, Hofman, Véronique, Lalvée, Salomé, Tanga, Virginie, Zahaf, Katia, Bonnetaud, Christelle, Lespinet, Virginie, Camuzard, Olivier, Montaudié, Henri, Poissonnet, Gilles, Passeron, Thierry, Ilié, Marius, Hofman, Paul

Volltext

Loss of LYN Is Frequent in Targeted Therapy–Resistant Melanoma Cells and Favors Metastatic Properties von Gaudel, Céline, Pisibon, Céline, Soysouvanh, Frédéric, Giuliano, Serena, Picard-Gauci, Alexandra, Leclerc, Justine, Hofman, Paul, Bahadoran, Philippe, Bertolotto, Corine, Ballotti, Robert

Volltext

Tocilizumab for Corticosteroid-Refractory Immune Checkpoint Inhibitor–Induced Generalized Morphea von Blaise, Manon, Cardot-Leccia, Nathalie, Seitz-Polski, Barbara, Picard-Gauci, Alexandra, Bertold, Clémence, Passeron, Thierry, Montaudié, Henri

Volltext

New Targeted Therapies and Immunotherapies for Locally Advanced Periocular Malignant Tumours: Towards a New 'Eye-Sparing' Paradigm? von Martel, Arnaud, Lassalle, Sandra, Picard-Gauci, Alexandra, Gastaud, Lauris, Montaudie, Henri, Bertolotto, Corine, Nahon-Esteve, Sacha, Poissonnet, Gilles, Hofman, Paul, Baillif, Stephanie

Volltext

Small but Challenging Conjunctival Melanoma: New Insights, Paradigms and Future Perspectives von Nahon-Esteve, Sacha, Bertolotto, Corine, Picard-Gauci, Alexandra, Gastaud, Lauris, Baillif, Stephanie, Hofman, Paul, Groulier, Anais, Maschi, Celia, Caujolle, Jean-Pierre, Lassalle, Sandra, Martel, Arnaud

Volltext

Cetuximab is efficient and safe in patients with advanced cutaneous squamous cell carcinoma: a retrospective, multicentre study von Montaudié, Henri, Viotti, Julien, Combemale, Patrick, Dutriaux, Caroline, Dupin, Nicolas, Robert, Caroline, Mortier, Laurent, Kaphan, Régis, Duval-Modeste, Anne-Bénédicte, Dalle, Stéphane, De Quatrebarbes, Julie, Stefan, Andrea, Brunet-Possenti, Florence, Kogay, Maria, Picard-Gauci, Alexandra, Poissonnet, Gilles, Peyrade, Frédéric

Volltext

ITGBL1 is a new immunomodulator that favors development of melanoma tumors by inhibiting natural killer cells cytotoxicity (vol 20, 12, 2021) von Cheli, Yann, Tulic, Meri K., El Hachem, Najla, Nottet, Nicolas, Jacquel, Arnaud, Gesson, Maeva, Strub, Thomas, Bille, Karine, Picard-Gauci, Alexandra, Montaudie, Henri, Beranger, Guillaume E., Passeron, Thierry, Close, Pierre, Bertolotto, Corine, Ballotti, Robert

Volltext